Publication: 3102

Publication: 3102

Prognostic and predictive impact of NPM1/FLT3-ITD genotypes as defined by 2017 European LeukemiaNet (ELN) risk categorization from randomized patients with acute myeloid leukemia (AML) treated within the International RATIFY Study (ALLIANCE 10603)

DOI

URL

Google Scholar

Citation:: HemaSphere vol 3 (S1) 81–82

Meeting Instance:: EHA 2019
Year:: 2019
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3235

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Novartis
Grants:: U10CA180821, U10CA180882, U24CA196171;

Corr. Author:
Authors:: Konstanze Döhner Christian Thiede Nikolaus Jahn Ekaterina Panina Agnes Gambietz Thomas W Prior Guido Marcucci Dan Jones Jürgen Krauter Michael Heuser Francesco Lo Coco Tiziana Ottone Josep Nomdedeu Sumithra J Mandrekar Ben L. Sanford Kristine Laumann Susan M. Geyer Rebecca B. Klisovic Andrew Wei Jorge Sierra Miguel A. Sanz Joseph M. Brandwein T. M. M de Witte Joop H. Jansen Dietger Niederwieser Frederick R. Appelbaum Bruno C Medeiros Martin S. Tallman Richard F. Schlenk Arnold Ganser Hubert Serve Gerhard Ehninger Sergio Amadori Insa Gathmann Axel Benner Celine Pallaud Richard A. Larson Richard M. Stone Hartmut Döhner Clara D. Bloomfield

Networks:

Study: ACOSOG-Z901101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords: